Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 91521

2 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
January 10, 2023
Product types
Drug
Classifications
Class II
Statuses
Ongoing
Recalling firm wording
Consolidated Chemical, Inc

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

2 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 2

Techni-Care Chloroxylenold 3%, [4 fl oz /118 mL or 8 fl oz/236 mL] per bottle, Care-Tech Laboratories, Inc., Saint Louis, Missouri 63139. NDC 4 oz bottle: 46706-222-01; NDC 8 oz: 46706-222-02

D-0325-2023
Recall number
D-0325-2023
Initiated
January 10, 2023
Classification
Class II
Status
Ongoing
Quantity
4 oz: 6580 bottles; 8 oz: 1248 bottles

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
CGMP Deviations: initiated due to violations

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

CGMP Deviations: initiated due to violations of CGMP manufacturing practices

Code information

Lots 3217A and 3217B, exp 06/23

Distribution pattern

Nationwide in the USA

drug · product 2 of 2

Humatrix Microclysmic Gel, 8 oz per bottle, Care-Tech Laboratories, Inc., Saint Louis, Missouri 63139.

D-0326-2023
Recall number
D-0326-2023
Initiated
January 10, 2023
Classification
Class II
Status
Ongoing
Quantity
3186 bottles

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
CGMP Deviations: initiated due to violations

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

CGMP Deviations: initiated due to violations of CGMP manufacturing practices

Code information

Lot, expiry: Lot 3216, exp 04/23 and 3218, exp 10/23

Distribution pattern

Nationwide in the USA